NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance

[1]  D. Yoon,et al.  Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway. , 2015, Biochemical and biophysical research communications.

[2]  Young-Kyoung Lee,et al.  Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression , 2015, Hepatology.

[3]  Weihua Ren,et al.  P15 gene methylation in hepatocellular carcinomas: a systematic review and meta-analysis. , 2015, International journal of clinical and experimental medicine.

[4]  A. Gasbarrini,et al.  The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing , 2015, Scientific Reports.

[5]  R. Tomasini,et al.  IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. , 2014, The Journal of clinical investigation.

[6]  J. Visvader,et al.  Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. , 2014, Cancer research.

[7]  D. Bachvarov,et al.  Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells , 2013, PloS one.

[8]  S. Dooley,et al.  Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines , 2013, PloS one.

[9]  S. Kwon,et al.  Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. , 2013, Carcinogenesis.

[10]  J. McCubrey,et al.  Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells , 2013, PloS one.

[11]  A. Bräuninger,et al.  Induction of Endoplasmic Reticulum Stress by Sorafenib and Activation of NF-κB by Lestaurtinib as a Novel Resistance Mechanism in Hodgkin Lymphoma Cell Lines , 2012, Molecular Cancer Therapeutics.

[12]  B. le Bail,et al.  Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death , 2012, Molecular Cancer Therapeutics.

[13]  Daniel J. Devine,et al.  Cytoplasmic translocation of p21 mediates NUPR1‐induced chemoresistance , 2012, FEBS letters.

[14]  J. McCubrey,et al.  Molecular mechanisms of sorafenib action in liver cancer cells , 2012, Cell cycle.

[15]  W. Shi,et al.  Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma , 2012, Tumor Biology.

[16]  R. Schmid,et al.  Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. , 2012, The Journal of clinical investigation.

[17]  J. McCubrey,et al.  Targeted therapy for hepatocellular carcinoma: novel agents on the horizon , 2012, Oncotarget.

[18]  Grace S. Shieh,et al.  Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model. , 2012, Carcinogenesis.

[19]  M. Miyazaki,et al.  Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma , 2012, BMC Cancer.

[20]  H. Azuma,et al.  Sorafenib increases endoplasmic reticulum (ER) stress in concert with vorinostat , 2011, Cancer biology & therapy.

[21]  J. Dagorn,et al.  p8 Expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis , 2011, Journal of cellular physiology.

[22]  M. Vettraino,et al.  Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. , 2011, European journal of pharmacology.

[23]  Kuen-Feng Chen,et al.  Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. , 2011, Journal of hepatology.

[24]  S. Qiu,et al.  Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis , 2011, Autophagy.

[25]  J. Iovanna,et al.  Nupr1: The Swiss‐knife of cancer , 2011, Journal of cellular physiology.

[26]  A. Arlt,et al.  Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis. , 2011, European journal of cell biology.

[27]  Lincoln D. Stein,et al.  Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. , 2011, Cancer cell.

[28]  Stephanie Roessler,et al.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.

[29]  J. Iovanna,et al.  Stress Proteins and Pancreatic Cancer Metastasis , 2010, TheScientificWorldJournal.

[30]  J. McCubrey,et al.  Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells , 2010, Cell cycle.

[31]  Marjorie E. Adams,et al.  Targeting , 2019, Systems Engineering for Ethical Autonomous Systems.

[32]  R. Fisher,et al.  Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[33]  Q. Xiong,et al.  Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[34]  R. Fisher,et al.  Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma , 2009, Molecular medicine.

[35]  Jorng-Tzong Horng,et al.  Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma , 2008, Oncogene.

[36]  Derek Y. Chiang,et al.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. , 2008, Cancer research.

[37]  V. Mazzaferro,et al.  Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.

[38]  Xin Wei Wang,et al.  Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma , 2007, Clinical Cancer Research.

[39]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[40]  M. Piris,et al.  The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. , 2006, Cancer cell.

[41]  F. Porteu,et al.  B56‐containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX‐1 and ERK , 2006, The EMBO journal.

[42]  J. Dagorn,et al.  p8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[43]  J. Dagorn,et al.  Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity , 2005, Hepatology.

[44]  D. Auclair,et al.  BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis , 2004, Cancer Research.

[45]  R. Rutherford,et al.  Identification of Potential Modifiers of Runx2/Cbfa1 Activity in C2C12 Cells in Response to Bone Morphogenetic Protein-7 , 2004, Cells Tissues Organs.

[46]  J. Alexander,et al.  Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7 , 2003, Molecular and Cellular Endocrinology.

[47]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[48]  M. Brentani,et al.  Expression of a novel factor, com1, in early tumor progression of breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  E. Hovig,et al.  Expression of a novel factor in human breast cancer cells with metastatic potential. , 1999, Cancer research.

[50]  J. Iovanna,et al.  Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth* , 1997, The Journal of Biological Chemistry.